RTI Surgical Holdings, Inc.® Announces Sale of OEM Business and Preliminary Fourth Quarter and Full Year 2019 Revenues

UF Innovate | Sid Martin Biotech alum RTI Surgical Holdings, Inc., a global surgical implant company, announced a definitive agreement for the sale of the company’s OEM business to Montagu Private Equity LLP, a leading European private equity firm, for a total consideration of $490 million. The transaction is targeted to close in the first half of 2020.

“The sale of the OEM business to Montagu completes the first phase of our strategic transformation to reduce complexity, drive operational excellence and accelerate the growth of RTI Surgical,” said Camille Farhat, President and CEO. “We are excited about this transaction, not only because of the value that is immediately created but also because the OEM business is going to an experienced investor who understands the business and the expertise of the people and will support its growth and development.”

Learn more about RTI Surgical Holdings, Inc.® Announces Sale of OEM Business and Preliminary Fourth Quarter and Full Year 2019 Revenues.